KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of APRE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Aprea Therapeutics Inc. stock price ended at $5.20 on Friday, after losing 2.80%.
(Updated on Apr 26, 2024)

Sell candidate since Apr 24, 2024 Gain 0.58% PDF

The Aprea Therapeutics Inc. stock price fell by -2.80% on the last day (Friday, 26th Apr 2024) from $5.35 to $5.20. During the last trading day the stock fluctuated 3.00% from a day low at $5.05 to a day high of $5.20. The price has fallen in 7 of the last 10 days and is down by -8.93% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 thousand shares and in total, 5 thousand shares were bought and sold for approximately $24.62 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.07 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.51% during the next 3 months and, with a 90% probability hold a price between $4.64 and $7.30 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

APRE Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 22, 2024, and so far it has risen 1.56%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aprea Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.31 and $6.03. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Aprea Therapeutics Inc. stock

Aprea Therapeutics Inc. finds support from accumulated volume at $5.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.151 between high and low, or 3.00%. For the last week the stock has had daily average volatility of 7.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (APRE) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Aprea Therapeutics Inc. to open at $5.15, and during the day (based on 14 day Average True Range), to move between $4.73 and $5.67, which gives a possible trading interval of +/-$0.466 (+/-8.96%) up or down from last closing price. If Aprea Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 17.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.17 (0.58%) than the resistance at $5.70 (9.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aprea Therapeutics Inc. stock A Buy?

Aprea Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.932 Sell Candidate Unchanged

Predicted Opening Price for Aprea Therapeutics Inc. of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$5.15 ( 0.95%) $5.20

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for APRE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.30 1.96 %
R2 5.24 0.84 %
R1 5.21 0.158 %
Current price: 5.20
Support S1 5.09 -2.06 %
S2 5.06 -2.75 %
S3 5.00 -3.86 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.35 22.12 %
R2 6.16 18.46 %
R1 5.70 9.62 %
Current price 5.20
Support S1 5.17 -0.577%
S2 5.15 -0.97%
S3 5.12 -1.54%

FAQ

What is the symbol for Aprea Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Aprea Therapeutics Inc. is APRE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aprea Therapeutics Inc. Stock?
Aprea Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Aprea Therapeutics Inc. Stock?
Aprea Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aprea Therapeutics Inc. Stock.

What's the current price of Aprea Therapeutics Inc. Stock?
As of the end of day on the Apr 26, 2024, the price of an Aprea Therapeutics Inc. (APRE) share was $5.20.

What is the 52-week high and low for Aprea Therapeutics Inc. Stock?
The 52-week high for Aprea Therapeutics Inc. Stock is $8.85 and the 52-week low is $2.78.

What is the market capitalization of Aprea Therapeutics Inc. Stock?
As of the Apr 26, 2024, the market capitalization of Aprea Therapeutics Inc. is 29.052M.

When is the next earnings date for Aprea Therapeutics Inc.?
The upcoming earnings date for Aprea Therapeutics Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Aprea Therapeutics Inc.

Aprea Therapeutics. Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATR... APRE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT